Legendary country singer Dolly Parton has reportedly helped fund research behind the promising new coronavirus vaccine produced by Moderna.
Moderna’s vaccine, which is reportedly 94.5% effective, was funded partly by the Dolly Parton COVID-19 Research Fund, according to an article published Thursday in the New England Journal of Medicine.
Yes, Dolly Parton part-funded research which went towards the Moderna vaccine which has reported 94.5% effectiveness. pic.twitter.com/tdyFWRnvsz
— Richard Chambers (@newschambers) November 17, 2020
Parton’s research fund is listed as support along with the NIAID, National Institutes of Health (NIH), Emory University, Kaiser Washington, Vanderbilt University Medical Center, Emmes and the National Center for Advancing Translational Sciences. (RELATED: Dolly Parton Announces $1 Million Donation To Vanderbilt For Coronavirus Research)
The vaccine still has to receive approval by the Food and Drug Administration plus undergo a peer-review before it can be available to the public. The Moderna vaccine is the second reportedly effective vaccine produced in the United States.
Parton announced she was donating $1 million to a COVID-19 research fund back in April.
“My longtime friend Dr. Naji Abumrad, who’s been involved in research at Vanderbilt for many years, informed me that they were making some advancements towards research of the coronavirus for a cure,” Parton said at the time. “I am making a donation of $1 million to Vanderbilt towards that research and to encourage people that can afford it to make donations.”
View this post on Instagram
Parton has always proven herself to be an American hero, but she really went all out with this one. She couldn’t have known that Moderna would be successful in producing a vaccine that is reportedly 94.5% effective, but she trusted that the U.S. could do it.
We really should change her name to Queen Dolly Parton.